12.360High12.100Low700Volume12.360Open12.680Pre Close8.60KTurnover0.00%Turnover Ratio--P/E (Static)0Shares16.75052wk High--P/B0Float Cap5.52052wk Low--Dividend TTM0Shs Float16.750Historical High--Div YieldTTM2.05%Amplitude0.464Historical Low12.285Avg Price1Lot Size
🔺obicetrapib是用于治疗低密度脂蛋白胆固醇(“LDL-C”)升高且有心血管疾病(“CVD”)风险的患者,这些患者现有疗法效果不够好或耐受性不佳
🔺本次临床试验的对象及其入选条件
Study Overview
Brief Summary
This study will be a placebo-controlled, double-blind, randomized, phase 3 study to Evaluate the Efficacy, Safety, and Tolerability of Obicetrapib in Participants with a History of Heterozygous Familial Hyper...
No comment yet